1. Diabetic macular edema (DME): A primer.- 2. Pathophysiology of diabetic macular edema (DME).- 3. OCT biomarkers for anti-VEGF therapy.- 4. Effect of anti-VEGF therapy on inner and outer retinal layers on SD-OCT.- 5. Angio-OCT in diabetic macular edema (DME).- 6. Macular ischemia and anti-VEGF therapy.- 7. Targetted screening for diabetic macular edema (DME): Translational aspects.- 8. DRCR.net trials for diabetic macular edema (DME).- 9. Anti-VEGF agents for diabetic macular edema (DME).- 10. TIE-Ang2 agents for diabetic macular edema (DME).- 11. Intravitreal dexamethasone implant for diabetic macular edema (DME).- 12. Laser photocoagulation for diabetic macular edema (DME).- 13. Surgical management of diabetic macular edema (DME).- 14. Diabetic macular edema (DME) - One minute preceptor.- 15. Artificial intelligence in diabetic macular edema (DME).- 16. End points of anti-VEGF clinical trials for diabetic macular edema (DME).- 17. Adjuvant therapies in diabetic macular edema (DME).- 18. QOL in diabetic macular edema (DME).- 19. Diabetic macular edema (DME) in young adults.- 20. Diabetic retinopathy and diabetic macular edema (DME): Fighting the emerging global disease.